5 Stocks Dragging In The Health Services Industry

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 72 points (-0.5%) at 15,564 as of Friday, Sept. 20, 2013, 12:54 PM ET. The NYSE advances/declines ratio sits at 854 issues advancing vs. 2,087 declining with 92 unchanged.

The Health Services industry currently sits up 0.4% versus the S&P 500, which is down 0.4%. On the negative front, top decliners within the industry include Insulet Corporation ( PODD), down 5.3%, Catamaran ( CTRX), down 3.5%, Brookdale Senior Living ( BKD), down 2.2% and HCA Holdings ( HCA), down 1.1%. Top gainers within the industry include Agilent Technologies ( A), up 1.8%, Grifols ( GRFS), up 1.3%, Cigna ( CI), up 1.2% and UnitedHealth Group ( UNH), up 0.7%.

TheStreet would like to highlight 5 stocks pushing the industry lower today:

5. ResMed ( RMD) is one of the companies pushing the Health Services industry lower today. As of noon trading, ResMed is down $0.63 (-1.2%) to $53.16 on average volume. Thus far, 585,150 shares of ResMed exchanged hands as compared to its average daily volume of 1.0 million shares. The stock has ranged in price between $52.88-$53.74 after having opened the day at $53.51 as compared to the previous trading day's close of $53.79.

ResMed Inc., through its subsidiaries, engages in the development, manufacture, and distribution of medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders. ResMed has a market cap of $7.6 billion and is part of the health care sector. Shares are up 30.8% year to date as of the close of trading on Thursday. Currently there are 7 analysts that rate ResMed a buy, no analysts rate it a sell, and 4 rate it a hold.

TheStreet Ratings rates ResMed as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, expanding profit margins and good cash flow from operations. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full ResMed Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

4. As of noon trading, Tenet Healthcare ( THC) is down $0.79 (-1.9%) to $41.98 on average volume. Thus far, 998,160 shares of Tenet Healthcare exchanged hands as compared to its average daily volume of 1.6 million shares. The stock has ranged in price between $41.66-$42.86 after having opened the day at $42.82 as compared to the previous trading day's close of $42.77.

Tenet Healthcare Corporation, an investor-owned health care services company, owns and operates acute care hospitals, ambulatory surgery centers, diagnostic imaging centers, urgent care centers, and related health care facilities in the United States. Tenet Healthcare has a market cap of $4.2 billion and is part of the health care sector. Shares are up 28.4% year to date as of the close of trading on Thursday. Currently there are 7 analysts that rate Tenet Healthcare a buy, no analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates Tenet Healthcare as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, generally higher debt management risk and disappointing return on equity. Get the full Tenet Healthcare Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

3. As of noon trading, Community Health Systems ( CYH) is down $1.16 (-2.8%) to $40.10 on heavy volume. Thus far, 1.5 million shares of Community Health Systems exchanged hands as compared to its average daily volume of 1.8 million shares. The stock has ranged in price between $39.84-$41.46 after having opened the day at $41.28 as compared to the previous trading day's close of $41.26.

Community Health Systems, Inc., together with its subsidiaries, provides general and specialized hospital healthcare services to patients in the United States. Community Health Systems has a market cap of $4.0 billion and is part of the health care sector. Shares are up 37.5% year to date as of the close of trading on Thursday. Currently there are 10 analysts that rate Community Health Systems a buy, no analysts rate it a sell, and 7 rate it a hold.

TheStreet Ratings rates Community Health Systems as a hold. The company's strengths can be seen in multiple areas, such as its reasonable valuation levels and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and poor profit margins. Get the full Community Health Systems Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

2. As of noon trading, Becton Dickinson ( BDX) is down $0.72 (-0.7%) to $102.15 on average volume. Thus far, 401,955 shares of Becton Dickinson exchanged hands as compared to its average daily volume of 836,800 shares. The stock has ranged in price between $101.88-$102.97 after having opened the day at $102.97 as compared to the previous trading day's close of $102.87.

Becton, Dickinson and Company, a medical technology company, develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide. The company's BD Medical segment produces medical devices that are used in various healthcare settings. Becton Dickinson has a market cap of $19.6 billion and is part of the health care sector. Shares are up 28.9% year to date as of the close of trading on Thursday. Currently there are 4 analysts that rate Becton Dickinson a buy, 4 analysts rate it a sell, and 8 rate it a hold.

TheStreet Ratings rates Becton Dickinson as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, largely solid financial position with reasonable debt levels by most measures, expanding profit margins and notable return on equity. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Becton Dickinson Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

1. As of noon trading, Boston Scientific ( BSX) is down $0.08 (-0.6%) to $11.66 on light volume. Thus far, 5.3 million shares of Boston Scientific exchanged hands as compared to its average daily volume of 17.1 million shares. The stock has ranged in price between $11.63-$11.85 after having opened the day at $11.81 as compared to the previous trading day's close of $11.74.

Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. Boston Scientific has a market cap of $16.0 billion and is part of the health care sector. Shares are up 107.7% year to date as of the close of trading on Thursday. Currently there are 4 analysts that rate Boston Scientific a buy, no analysts rate it a sell, and 15 rate it a hold.

TheStreet Ratings rates Boston Scientific as a buy. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, solid stock price performance, expanding profit margins, impressive record of earnings per share growth and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Boston Scientific Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you are interested in one of these 5 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

null

More from Markets

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing